Toyobo Co., Ltd. · TSE:3101

Toyobo — H1 FY3/23 Earnings Presentation

20 slides from Toyobo's earnings presentation, Nov 10, 2022

  1. Slide 1: Presentation to Investors for the First Half Ended September 30, 2022

    November 10, 2022 Presentation to Investors for the First Half Ended September 30, 2022 TOYOBO CO., LTD.

  2. Slide 2: Highlights

    Highlights H1 FY 3/23 Results Amid rising demand for PCR testing, sales increased while operating profit decreased due to the impact of rising raw material and fuel prices and a deterioration in the market for industrial film. Profit of ¥11.0 bn, a year-on-year increase due to extraordinary income.

  3. Slide 3: Summary of Results: P&L

    Summary of Results: P&L (¥bn.) FY 3/22 FY 3/23 YOY H1 H2 H1 Amount % Net sales 183.9 191.9 201.1 + 17.3 + 9.4% Operating profit 17.1 11.3 7.9 - 9.2 - 53.9% (Ratio to sales) 9.3% 5.9% 3.9% - - Ordinary profit 13.3 9.8 6.8 - 6.5 - 49.2% Extraordinary income and losses - 1.8 - 6.5 8.1 - - Profit attrib

  4. Slide 4: Analysis in Changes in Operating Profit

    Analysis in Changes in Operating Profit Raw materials 20.0 and fuel costs - 11.0 Prices Volume 15.0 Others +7.8 - 1.2 - 4.8 10.0 (¥bn.) 17.1 - R&D and testing expenses - Cost to launch new unit 5.0 - Packaging film of films 7.9 - Airbag fabrics etc. - Development of the business base ( - 9.2 ) - Ind

  5. Slide 5: Summary of Results: BS

    Summary of Results: BS (B) (A) (¥bn.) Mar. 31, 2021 Mar. 31, 2022 Sep. 30, 2022 (A) - (B) Total assets 491.2 517.8 541.2 + 23.4 Cash and deposits 34.7 27.2 28.9 + 1.7 Inventories 76.3 96.0 114.5 + 18.4 Property, plant and equipment 224.6 227.6 236.3 + 8.7 Net assets 188.6 197.1 207.0 + 9.8 Sharehold

  6. Slide 6: Summary of Results: Segment

    Summary of Results: Segment (¥bn.) Net sales Operating profit H1 FY 3/22 H1 FY 3/23 H1 FY 3/22 H1 FY 3/23 YOY Films and Functional Materials 85.9 86.7 12.2 4.2 - 8.0 Mobility 21.6 24.1 - 0.9 - 2.0 - 1.2 Lifestyle and Environment 54.7 64.6 1.9 1.2 - 0.7 Life Science 16.3 19.3 4.6 5.4 + 0.8 Real Estat

  7. Slide 7: Films and Functional Materials

    Films and Functional Materials (¥bn.) FY 3/22 FY 3/23 YOY Q1 Q2 H1 Q1 Q2 H1 Amount % Net sales 45.7 40.2 85.9 45.3 41.4 86.7 + 0.8 +0.9% Operating profit 6.8 5.4 12.2 3.5 0.7 4.2 - 8.0 - 65.4% (OPM) 14.9% 13.5% 14.2% 7.8% 1.7% 4.9% ‐ ‐ Packaging film - Sales were firm but product price revisions cou

  8. Slide 8: Mobility

    Mobility (¥bn.) FY 3/22 FY 3/23 YOY Q1 Q2 H1 Q1 Q2 H1 Amount % Net sales 11.1 10.5 21.6 11.8 12.3 24.1 + 2.6 +12.0% Operating profit - 0.5 - 0.4 - 0.9 - 0.8 - 1.3 - 2.0 - 1.2 ‐ (OPM) - - - - - - ‐ ‐ Engineering plastics - Both in Japan and overseas, product price revisions could not keep up with ris

  9. Slide 9: Lifestyle and Environment

    Lifestyle and Environment (¥bn.) FY 3/22 FY 3/23 YOY Q1 Q2 H1 Q1 Q2 H1 Amount % Net sales 27.7 27.0 54.7 32.1 32.5 64.6 + 9.9 + 18.1% Operating profit 1.5 0.4 1.9 0.3 0.9 1.2 - 0.7 - 35.1% (OPM) 5.4% 1.4% 3.4% 0.9% 2.9% 1.9% ‐ ‐ Environmental solutions - Sales of VOC treatment equipment and replacem

  10. Slide 10: Life Science

    Life Science (¥bn.) FY 3/22 FY 3/23 YOY Q1 Q2 H1 Q1 Q2 H1 Amount % Net sales 7.5 8.9 16.3 8.7 10.6 19.3 + 3.0 + 18.1% Operating profit 1.9 2.8 4.6 2.1 3.3 5.4 + 0.8 + 17.3% (OPM) 24.9% 31.1% 28.2% 24.6% 30.9% 28.0% ‐ ‐ Biotechnology - Sales of raw materials and reagents for PCR testing grew as a res

  11. Slide 11: Forecasts for FY 3/23

    Forecasts for FY 3/23 Continue to carry out price shifts, but revise operating profit to ¥17.0 bn, based on the impact of raw material and fuel prices remaining high, delays in the recovery of automobile production, and adjustments of home appliances and smartphone inventories. Net profit is forecas

  12. Slide 12: Analysis in Changes in Operating Profit

    Analysis in Changes in Operating Profit Raw materials and fuel costs 30.0 - 18.0 Prices Volume +14.3 - 1.8 Others 25.0 - 5.9 20.0 (¥bn.) 15.0 - R&D and testing expenses 28.4 - Cost to launch new unit of films 10.0 - Packaging film - Development of the 17.0 - Airbag fabrics etc. business base ( - 11.

  13. Slide 13: Forecasts by Segment

    Forecasts by Segment (¥bn.) Net sales Operating profit FY 3/22 FY 3/23 FY 3/22 FY 3/23 Previous forecasts YOY (Aug. results forecasts results forecasts 2022) Films and Functional Materials 170.3 178.0 19.9 10.0 - 9.9 18.5 Mobility 44.7 53.0 - 1.8 - 3.4 - 1.6 - 2.3 Lifestyle and Environment 114.3 130

  14. Slide 14: Appendix

    TOYOBO Appendix

  15. Slide 15: Business Performance

    Business Performance (¥bn.) FY 3/22 FY 3/23 Net sales Q1 Q2 Q3 Q4 Full year Q1 Q2 Films and Funcitonal Materials 45.7 40.2 41.4 43.0 170.3 45.3 41.4 Mobility 11.1 10.5 10.6 12.6 44.7 11.8 12.3 Lifestyle and Environment 27.7 27.0 27.7 31.9 114.3 32.1 32.5 Life Science 7.5 8.9 8.2 10.4 35.0 8.7 10.6 R

  16. Slide 16: Topics: Films Business

    Topics: Films Business Expanded processing equipment for mold releasing film for MLCC - MLCC market: Growth of 7% or more annually - The only manufacturer in Japan that can handle full-scale production, from base film to coating release layers. - Share: Approx. 25 % (TOYOBO’s estimate), a world-lead

  17. Slide 17: Topics: Life Science Business

    Topics: Life Science Business Dedicated reagent for fully automated gene analysis system “GENECUBE” - Multiple items can be measured simultaneously (4 items×6 specimens maximum) COVID-19 and Influenza virus Whooping cough and Mycoplasma pneumoniae Pertussis (whooping cough) and Parapertussis (Insura

  18. Slide 18: Topics: Integrated Report

    Topics: Integrated Report Integrated “TOYOBO REPORT 2022” released Main contents - “Sustainable Vision 2030”, ”2025 Medium-Term Management Plan“ - Mitsubishi Corporation and Toyobo top management discuss the new joint venture, Dialogue with ESG Investors - Employee round-table discussion, outside di

  19. Slide 19: Please Note

    Please Note The business performance forecasts and targets included in the business plans contained in this presentation are based on information known to the Company’s management as of the day of presentation. Please be aware that the content of the future forecasts may differ significantly from ac

  20. Slide 20: ©️ TOYOBO CO., LTD. All rights reserved.

    ©️ TOYOBO CO., LTD. All rights reserved.

Toyobo — H1 FY3/23 Earnings Presentation on 6ix